Addex Therapeutics Ltd. (ADXN)
3.75
-0.30
(-7.41%)
USD |
NASDAQ |
Aug 25, 16:00
3.76
+0.01
(+0.27%)
After-Hours: 19:59
Addex Therapeutics Shareholders Equity (Quarterly) : 4.087M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 4.087M |
| December 31, 2025 | 6.010M |
| September 30, 2025 | 7.480M |
| June 30, 2025 | 9.052M |
| March 31, 2025 | 9.369M |
| December 31, 2024 | 10.67M |
| September 30, 2024 | 13.11M |
| June 30, 2024 | 14.08M |
| March 31, 2024 | -1.527M |
| December 31, 2023 | 1.36M |
| September 30, 2023 | 4.311M |
| June 30, 2023 | 6.829M |
| March 31, 2023 | 4.452M |
| December 31, 2022 | 5.307M |
| September 30, 2022 | 8.079M |
| June 30, 2022 | 7.164M |
| March 31, 2022 | 14.08M |
| December 31, 2021 | 18.56M |
| September 30, 2021 | 14.30M |
| June 30, 2021 | 17.73M |
| March 31, 2021 | 21.99M |
| December 31, 2020 | 16.45M |
| September 30, 2020 | 17.14M |
| June 30, 2020 | 19.84M |
| March 31, 2020 | 22.51M |
| Date | Value |
|---|---|
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Novartis AG | 41.54B |
| Roche Holding AG | -- |
| Oculis Holding AG | 271.91M |
| Sandoz Group AG | -- |
| Galderma Group AG | -- |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.920M |
| Total Liabilities (Quarterly) | 1.832M |
| Debt to Equity Ratio | 0.0311 |
| Current Ratio | 0.9715 |
| Net Debt Paydown Yield | -0.26% |